BlackRock Health Sciences Trust II (BMEZ) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.00x

BlackRock Health Sciences Trust II (BMEZ) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $6.00 (capex $6.00 ) from operating cash flow of $78.91 Million. Explore BlackRock Health Sciences Trust II capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$6.00
Capex + Investments

Operating Cash Flow

$78.91 Million
USD

Capital Expenditures

$6.00
USD

BlackRock Health Sciences Trust II Cash Flow Reinvestment Rate (2020–2024)

Historical reinvestment intensity for BlackRock Health Sciences Trust II across 3 annual periods. Also explore how large is BlackRock Health Sciences Trust II's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BlackRock Health Sciences Trust II (2020–2024)

Year-by-year capital reinvestment analysis for BlackRock Health Sciences Trust II. For live market cap and broader valuation context, see BMEZ stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.00x $0.00 $65.52 Million $0.00
2023 0.00x $0.00 $32.02 Million $0.00
2020 0.00x $0.00 $107.17 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow